Today (30 January 2025) two scientists from the UK received Thailand’s Prince Mahidol Awards (PMA) for 2024 for their long and significant contribution in the field of Public Health and Medicine. Dr Jonathan Shepherd, a British surgeon and professor at Cardiff University in Wales, and Dr Tony Hunter (dual US-UK national), a professor of Biology at the Salk Institute for Biological Studies, USA have received the award, following on from Professor David Mabey, who received the award in 2019 for his work to eradicate trachoma, the most common infectious cause of blindness worldwide.
The Award Presentation Ceremony was held at Thailand’s Royal Palace. Her Royal Highness Princess Maha Chakri Sirindhorn, as the representative of His Majesty the King, presided over the Presentation Ceremony, in the company of the Privy Council, Bureau of the Royal Household and Cabinet members.
Dr Shepherd receives the Prince Mahidol Award (PMA) in Public Health for his creation of the ‘Cardiff Model of Violence Prevention’ which is an evidence-based, multisectoral approach to violence prevention which has been endorsed by the World Health Organisation and integrated into multisectoral approaches to violence prevention from South Africa to Australia. Dr Shepherd’s research and commitment to evidence-based public policy has contributed to the development of ‘What Works Network’. The Network, supported by the UK government, acts as an important interface between research and policymaking, ensuring that policy makers have access to the best evidence.
Professor Hunter who studied at the University of Cambridge in the UK, receives the Prince Mahidol Award in Medicine for his discovery of tyrosine kinase enzymes and the phosphorylation process, a crucial mechanism that transforms normal cells into cancerous cells. This breakthrough discovery led to the development of targeted cancer treatments and pharmaceutical innovation that can effectively inhibit cancer cells.
In 2024 the UK and Thailand established a Strategic Partnership, highlighting a shared commitment to advance global health by championing universal access to health care and strengthening partnerships to prevent, detect and respond to global health threats. This includes joint efforts to tackle antimicrobial resistance and infectious disease outbreaks including through the development and application of innovative technology, such as genomics.
